Key result
Dysfunctional thrombomodulin expression in diabetic ApoE-/- mice reduced atherosclerotic plaque stability, characterized by larger necrotic cores and decreased fibrous cap thickness.
Why the study?
Diabetes-associated atherosclerosis is characterized by impaired plaque stability and lacks efficient therapeutic concepts, while being associated with reduced endothelial thrombomodulin expression and impaired activated protein C generation.
Does impaired thrombomodulin function reduce atherosclerotic plaque stability in diabetic mice?
Does impaired thrombomodulin function reduce atherosclerotic plaque stability in diabetic mice?
Impaired thrombomodulin function reduces plaque stability in a mouse model of diabetes-associated atherosclerosis, highlighting a potential mechanism for plaque vulnerability in diabetic patients.
May support TM/aPC pathway investigation in diabetic atherosclerosis; leaves open whether targeting improves plaque stability or clinical outcomes.
Diabetes mellitus, which is largely driven by nutritional and behavioral factors, is characterized by accelerated atherosclerosis with impaired plaque stability. Atherosclerosis and associated complications are the major cause of mortality in diabetic patients. Efficient therapeutic concepts for diabetes-associated atherosclerosis are lacking. Atherosclerosis among diabetic patients is associated with reduced endothelial thrombomodulin (TM) expression and impaired activated protein C (aPC) generation. Here, we demonstrate that atherosclerotic plaque stability is reduced in hyperglycemic mice expressing dysfunctional TM (TMPro/Pro mice), which have a pro-coagulant phenotype due to impaired thrombin inhibition and markedly reduced aPC generation. The vessel lumen and plaque size of atherosclerotic lesions in the truncus brachiocephalic were decreased in diabetic TMPro/Pro ApoE-/- mice compared to diabetic ApoE-/- mice. While lipid accumulation in lesions of diabetic TMPro/Pro ApoE-/- mice was lower than that in diabetic ApoE-/- mice, morphometric analyses revealed more prominent signs of instable plaques, such as a larger necrotic core area and decreased fibrous cap thickness in diabetic TMPro/Pro ApoE-/- mice. Congruently, more macrophages and fewer smooth muscle cells were observed within lesions of diabetic TMPro/Pro ApoE-/- mice. Thus, impaired TM function reduces plaque stability, a characteristic of hyperglycemia-associated plaques, thus suggesting the crucial role of impaired TM function in mediating diabetes-associated atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Ambreen et al. (2022) studied Diabetes-induced atherosclerosis. Dysfunctional thrombomodulin (TMPro/Pro mutation) vs. Diabetic ApoE-/- mice was evaluated on Atherosclerotic plaque stability (necrotic core area, fibrous cap thickness, cellular composition). Dysfunctional thrombomodulin expression in diabetic ApoE-/- mice reduced atherosclerotic plaque stability, characterized by larger necrotic cores and decreased fibrous cap thickness.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: